CRMEX
Price
$5.67
Change
-$0.00 (-0.00%)
Updated
Apr 17 closing price
Net Assets
19.78M
VEXMX
Price
$123.00
Change
+$0.98 (+0.80%)
Updated
Apr 17 closing price
Net Assets
101.44B
Ad is loading...

CRMEX vs VEXMX

Header iconCRMEX vs VEXMX Comparison
Open Charts CRMEX vs VEXMXBanner chart's image
CRM All Cap Value I
Price$5.67
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets19.78M
Vanguard Extended Market Index Investor
Price$123.00
Change+$0.98 (+0.80%)
VolumeN/A
Net Assets101.44B
CRMEX vs VEXMX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CRMEX vs. VEXMX commentary
Apr 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRMEX is a Buy and VEXMX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VEXMX has more cash in the bank: 101B vs. CRMEX (19.8M). VEXMX pays higher dividends than CRMEX: VEXMX (1.15) vs CRMEX (0.00). CRMEX was incepted earlier than VEXMX: CRMEX (18 years) vs VEXMX (37 years). CRMEX (1.48) is less costly to investors than VEXMX (0.19). CRMEX is a more actively managed with annual turnover of: 54.00 vs. VEXMX (11.00). CRMEX has a lower initial minimum investment than VEXMX: CRMEX (2500) vs VEXMX (3000). VEXMX annual gain was more profitable for investors over the last year : -0.67 vs. CRMEX (-14.86). VEXMX return over 5 years is better than : 64.03 vs. CRMEX (9.99).
CRMEXVEXMXCRMEX / VEXMX
Total Expense Ratio1.460.19768%
Annual Report Gross Expense Ratio1.480.19779%
Fund Existence18 years37 years-
Gain YTD-17.467-15.318114%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets19.8M101B0%
Annual Yield % from dividends0.001.15-
Returns for 1 year-14.86-0.672,222%
Returns for 3 years-21.102.13-989%
Returns for 5 years9.9964.0316%
Returns for 10 years-45.8578.39-58%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JDEUX38.64N/A
N/A
JPMorgan US Research Enhanced Equity R6
FEICX31.84N/A
N/A
Fidelity Advisor Equity Income C
IVKIX19.52N/A
N/A
VY® Invesco Comstock I
JGERX11.24N/A
N/A
JHancock Global Equity R2
MYIFX17.00N/A
N/A
Monetta Young Investor Growth